Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Dual Agonist Therapy Outperforms Monotherapy for Cardiorenal Health
Researchers recently analyzed extensive data from the SURPASS-CVOT clinical trial. They discovered that tirzepatide definitively outperforms dulaglutide for complex patient care. Consequently, this dual agonist significantly improves comprehensive cardiorenal outcomes across diverse medical populations. Investigators promptly published these vital medical…